# Jiangsu Weiqida Pharmaceutical Co., Ltd. – FDA Inspection, Dec 15, 2017

Source: https://www.keypedia.com/records/fda_inspections/jiangsu-weiqida-pharmaceutical-co-ltd/ab5f8eda-6119-432b-8290-67fa2cfe855a
Source feed: FDA_Inspections

> FDA inspection 1038055 of Jiangsu Weiqida Pharmaceutical Co., Ltd., December 15, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1038055
- Company Name: Jiangsu Weiqida Pharmaceutical Co., Ltd.
- Inspection Date: 2017-12-15
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1265662 - 2025-03-21](https://www.keypedia.com/records/fda_inspections/jiangsu-weiqida-pharmaceutical-co-ltd/7d9da020-6a1f-4404-9a66-c326e2e70c53)
- FDA Inspection 880208 - 2014-04-30

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/steven-p-donald/431cb518-7687-408b-82e4-e525a135a26b)

Company: https://www.keypedia.com/companies/jiangsu-weiqida-pharmaceutical-co-ltd/3210bab8-b3e8-495f-9a42-02405bb691f7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c